Loading...

Absci Corporation

ABSINASDAQ
Healthcare
Biotechnology
$3.94
$0.26(7.20%)
U.S. Market is Open • 13:13

Absci Corporation Fundamental Analysis

Absci Corporation (ABSI) shows weak financial fundamentals with a PE ratio of -5.12, profit margin of -41.14%, and ROE of -59.68%. The company generates $0.0B in annual revenue with weak year-over-year growth of -20.71%.

Key Strengths

Cash Position24.13%
PEG Ratio-0.58
Current Ratio6.57

Areas of Concern

ROE-59.68%
Operating Margin-44.79%
We analyze ABSI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -3136.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-3136.9/100

We analyze ABSI's fundamental strength across five key dimensions:

Efficiency Score

Weak

ABSI struggles to generate sufficient returns from assets.

ROA > 10%
-53.25%

Valuation Score

Excellent

ABSI trades at attractive valuation levels.

PE < 25
-5.12
PEG Ratio < 2
-0.58

Growth Score

Moderate

ABSI shows steady but slowing expansion.

Revenue Growth > 5%
-20.71%
EPS Growth > 10%
21.67%

Financial Health Score

Excellent

ABSI maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
6.57

Profitability Score

Weak

ABSI struggles to sustain strong margins.

ROE > 15%
-5968.36%
Net Margin ≥ 15%
-41.14%
Positive Free Cash Flow
No

Key Financial Metrics

Is ABSI Expensive or Cheap?

P/E Ratio

ABSI trades at -5.12 times earnings. This suggests potential undervaluation.

-5.12

PEG Ratio

When adjusting for growth, ABSI's PEG of -0.58 indicates potential undervaluation.

-0.58

Price to Book

The market values Absci Corporation at 3.11 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.11

EV/EBITDA

Enterprise value stands at -5.43 times EBITDA. This is generally considered low.

-5.43

How Well Does ABSI Make Money?

Net Profit Margin

For every $100 in sales, Absci Corporation keeps $-41.14 as profit after all expenses.

-41.14%

Operating Margin

Core operations generate -44.79 in profit for every $100 in revenue, before interest and taxes.

-44.79%

ROE

Management delivers $-59.68 in profit for every $100 of shareholder equity.

-59.68%

ROA

Absci Corporation generates $-53.25 in profit for every $100 in assets, demonstrating efficient asset deployment.

-53.25%

Following the Money - Real Cash Generation

Operating Cash Flow

Absci Corporation generates limited operating cash flow of $-94.41M, signaling weaker underlying cash strength.

$-94.41M

Free Cash Flow

Absci Corporation generates weak or negative free cash flow of $-95.54M, restricting financial flexibility.

$-95.54M

FCF Per Share

Each share generates $-0.62 in free cash annually.

$-0.62

FCF Yield

ABSI converts -15.44% of its market value into free cash.

-15.44%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.12

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.58

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.11

vs 25 benchmark

P/S Ratio

Price to sales ratio

213.96

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.57

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.60

vs 25 benchmark

ROA

Return on assets percentage

-0.53

vs 25 benchmark

ROCE

Return on capital employed

-0.65

vs 25 benchmark

How ABSI Stacks Against Its Sector Peers

MetricABSI ValueSector AveragePerformance
P/E Ratio-5.1228.71 Better (Cheaper)
ROE-59.68%690.00% Weak
Net Margin-4113.68%-44718.00% (disorted) Weak
Debt/Equity0.030.36 Strong (Low Leverage)
Current Ratio6.574.54 Strong Liquidity
ROA-53.25%-16533.00% (disorted) Weak

ABSI outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Absci Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

84.18%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-1210.45%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-904.42%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ